Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2) - Blauvelt, Andrew; Wollenberg, Andreas; Pink, Andrew; Peris, Ketty; Armstrong, April; Spelman, Lynda; Saeki, Hidehisa; Lynde, Charles; Herranz, Pedro; Barbarot, Sebastien; Simpson, Eric (JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021)